6/4/2026
University of Pittsburgh study finds implanted device boosts arm strength, cuts spasticity in stroke survivors — with fewer than nine hours of training.
PITTSBURGH — University of Pittsburgh School of Medicine researchers have published the final outcomes of a first-of-its-kind pilot clinical trial showing that electrical stimulation of the cervical spinal cord — the portion of the spinal cord in the neck — can improve arm strength and reduce spasticity in people living with chronic stroke. The findings were published on June 4, 2026, in Nature Medicine.
Stroke is the leading cause of adult arm paralysis in the United States. About 400,000 people develop lasting arm and hand weakness each year. Many rank recovery of arm function as their top unmet need, yet standard rehabilitation rarely drives meaningful improvement.
To address arm paralysis and chronic arm weakness after stroke, Pitt researchers launched the first clinical trial to test whether cervical epidural spinal cord stimulation — a method that uses thin metal electrodes implanted in the epidural space surrounding the cervical spinal cord — could help stroke survivors regain arm function. The intervention involved fewer than nine hours of movement-based training over four weeks.
Key Findings
-
Seven participants with chronic post-stroke arm weakness enrolled
-
Average 32% increase in arm strength when stimulation was active
-
Spasticity — abnormal muscle stiffness caused by stroke-damaged nerve pathways — reduced in all seven participants
-
No serious adverse events reported
How It Works
When activated, the implanted electrodes deliver targeted electrical pulses to sensory nerve fibers in the spinal cord. Stroke rarely destroys all connections between the brain and the spinal cord — it typically weakens them. The stimulation boosts those residual connections so they can produce functional movement. This type of approach, known as a neuroprosthetic technology — a device that interfaces with the nervous system to restore or supplement lost function — has been used for decades to treat chronic pain, but this is the first clinical trial to apply it to upper-limb rehabilitation after stroke.
"This approach is designed to rapidly help people move their arms better, even years after a stroke," said assistant professor of neurological surgery at Pitt Marco Capogrosso, Ph.D., co-senior author and director of the spinal cord stimulation laboratory at Rehab Neural Engineering Labs in the UPMC Rehabilitation Institute. "By stimulating the spinal cord, we can immediately allow residual connections between the brain and the spinal cord to work more efficiently, enabling better movement."
Researchers observed two distinct benefits. All seven participants showed immediate strength gains when stimulation was on, regardless of baseline severity. All seven also experienced reduced spasticity.
"Some of the improvements we measure may look small from the outside, but many stroke survivors are just on the verge of being able to do something important," said co-author George Wittenberg, M.D., Ph.D., professor of neurology and physical medicine and rehabilitation at Pitt. "Even a small change in motor function can be very significant if it helps someone button a shirt or open their hand."
Motor function declined when stimulation was discontinued — a finding that sharpens the central question driving the team's next clinical trial: whether longer durations of stimulation, combined with physical therapy, can convert the technology's immediate assistive benefits into lasting recovery. The result is analogous to a hearing aid that enables function while active, while leaving open the possibility that extended use may produce more durable gains.
The 2026 study expands on findings the same team first reported in Nature Medicine in 2023 and confirms safety and feasibility across a more diverse participant group over a full four-week intervention period. The research was recognized by the National Institute of Neurological Disorders and Stroke (NINDS) in its 75th anniversary report.
"This study represents an important step toward real-world clinical application," Capogrosso said. "These results give us confidence that spinal cord stimulation could become a practical, implantable option for helping stroke survivors use their arms when it matters most."
The research team began recruiting participants for an extended clinical trial (ClinicalTrials.gov NCT07153536) to evaluate longer-term stimulation, both alone and in combination with physical therapy. The expanded study will help identify which participants are most likely to benefit and optimize stimulation parameters for different levels of stroke severity — marking a pivotal step in translating a proof-of-concept finding into a potential clinical tool.
Frequently Asked Questions
Q: Does the improvement last after the stimulator is turned off?
A: In this seven-participant pilot trial, motor function remained improved but tended to decline when stimulation was discontinued, suggesting the device is more effective when it’s ON.
Q: Who might be a candidate for this type of treatment?
A: The trial enrolled adults with lasting arm and hand weakness from chronic stroke. Researchers are now working to identify which factors — including stroke severity and the degree of surviving neural connections — best predict who responds. The treatment is not yet available outside of clinical trials.
Q: How is this different from non-invasive stroke recovery devices?
A: Cervical epidural spinal cord stimulation delivers electrical pulses through implanted electrodes placed directly in the epidural space surrounding the spinal cord, targeting the nerve pathways that control arm and hand movement with a precision and intensity that external, non-invasive devices cannot currently replicate. The immediate, measurable strength gains observed in this trial reflect that direct access.
Additional Resources
- Published study: Spinal cord stimulation for upper limb motor function in people with chronic post-stroke hemiparesis: a feasibility trial, Nature Medicine
- Press release on EurekAlert!: Spinal cord stimulation improves arm function after stroke
- UPMC and Pitt Heath Sciences newsroom: Spinal Cord Stimulation Instantly Improves Arm Mobility After Stroke, February 20, 2023
- Related Pitt coverage: On its 75th Anniversary, NINDS Celebrates Pitt’s Spinal Cord Research
- Clinical trial information: NCT07153536
- Spinal Cord Stimulation, National Institute of Neurological Disorders and Stroke
Authors and Funding
Authors: University of Pittsburgh authors of this research include Roberto de Freitas, Ph.D., Shovan Bhatia, Ph.D., Erynn Sorensen, Ph.D., Erick Carranza, Ph.D., Scott Ensel, Ph.D., Amy Boos, O.T.R./L., M.S., Lee Fisher, Ph.D., Daryl Fields, Ph.D., Marc Powell, Ph.D., Jeffrey Balzer, Ph.D., Peter Gerszten, M.D., and Elvira Pirondini, Ph.D. Additional co-authors are from Carnegie Mellon University, Columbia University, the Veterans Affairs Pittsburgh Healthcare System and Johns Hopkins University.
Funding and Disclosures: This research was supported by the National Institutes of Health BRAIN Initiative (grant UG3NS123135‑01A1), internal funding from the departments of Neurological Surgery and Physical Medicine and Rehabilitation at Pitt, as well as the Department of Mechanical Engineering and the Neuroscience Institute at Carnegie Mellon University.
Video (click image and video will open in an additional screen)
Helping Stroke Survivors Regain Arm Movement
Caption: A University of Pittsburgh study conducted at the UPMC Mercy Pavilion found that spinal cord stimulation can help stroke survivors regain arm movement and ease muscle stiffness. In a small clinical trial, participants saw meaningful gains with limited rehabilitation, pointing to a potential new assistive option for recovery.
Credit: UPMC and University of Pittsburgh Health Sciences
